Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
McIntyre RS, Phan L, Kwan ATH, Mansur RB, Rosenblat JD, Guo Z, Le GH, Lui LMW, Teopiz KM, Ceban F, Lee Y, Bailey J, Ramachandra R, Di Vincenzo J, Badulescu S, Gill H, Drzadzewski P, Subramaniapillai M.
McIntyre RS, et al. Among authors: badulescu s.
Brain. 2024 Mar 1;147(3):849-857. doi: 10.1093/brain/awad377.
Brain. 2024.
PMID: 37936330
Clinical Trial.